| Medication preferences and adherence among individuals with severe mental illness and psychiatric advance directives. | |
| | |
MedLine Citation:
|
PMID: 20360277 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: Psychiatric advance directives allow patients with severe mental illness to document their preferences for particular medications. This study investigated the role of psychiatric advance directives in treatment choice and medication adherence. METHODS: A total of 123 persons with severe mental illness recorded medication preferences in psychiatric advance directives. The authors compared medication preferences to prescribed medications over 12 months, determined concordance between preferred and prescribed medications, and examined the effect of concordance on medication adherence at 12 months. RESULTS: Participants requested a median of two medications in their psychiatric advance directives (range from zero to six) and refused a median of one medication (range from zero to ten). Between baseline and follow-up there was a 27% increase in the number of medications prescribed that had been requested on the psychiatric advance directive (Wilcoxon matched pairs, p<.001). After correction for the number of medications listed in the psychiatric advance directive, a 10% increase in concordance remained significant (p<.001). Being prescribed at least one medication requested in the psychiatric advance directive predicted higher medication adherence at 12 months, after the analysis controlled for relevant covariates (odds ratio=7.8, 95% confidence interval=1.8-34.0). CONCLUSIONS: Providing information about medication preferences in psychiatric advance directives may increase prescribing of patient-preferred medications even in noncrisis settings. Patients who were prescribed medications that they requested in advance were significantly more likely to adhere to medications, supporting the benefit of patient participation in medication choice. Psychiatric advance directives appear to be a clinically useful conduit for communicating patient medication preferences. |
| | |
Authors:
|
Christine M Wilder; Eric B Elbogen; Lorna L Moser; Jeffrey W Swanson; Marvin S Swartz |
Related Documents
:
|
3294687 - Bereavement and its complications in medical patients: a guide for consultation-liaison... 12773277 - Electroconvulsive therapy in the medically ill. 17463337 - Psychiatrists and primary caring: what are our boundaries of responsibility? 17326547 - Comorbidity of chronic insomnia with medical problems. 1005577 - A method for decreasing patients' medication errors. 14655587 - Importing and exporting gametes and embryos under the infertility treatment act 1995 (v... |
Publication Detail:
|
Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Psychiatric services (Washington, D.C.) Volume: 61 ISSN: 1557-9700 ISO Abbreviation: Psychiatr Serv Publication Date: 2010 Apr |
Date Detail:
|
Created Date: 2010-04-02 Completed Date: 2010-06-30 Revised Date: 2010-11-05 |
Medline Journal Info:
|
Nlm Unique ID: 9502838 Medline TA: Psychiatr Serv Country: United States |
Other Details:
|
Languages: eng Pagination: 380-5 Citation Subset: IM |
Affiliation:
|
Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Box 3071, Durham, NC 27710, USA. christine.wilder@duke.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Advance Directives / legislation & jurisprudence*, psychology* Bipolar Disorder / drug therapy, psychology Depressive Disorder, Major / drug therapy, psychology Female Humans Male Medication Adherence / psychology*, statistics & numerical data Middle Aged Patient Preference / legislation & jurisprudence*, psychology* Psychiatric Status Rating Scales Psychotic Disorders / drug therapy* Psychotropic Drugs / therapeutic use* Schizophrenia / drug therapy Schizophrenic Psychology |
| Grant Support | |
ID/Acronym/Agency:
|
5-R01-MH-063949/MH/NIMH NIH HHS; K02-MH67864/MH/NIMH NIH HHS; T32-MH019117/MH/NIMH NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Psychotropic Drugs |
| Comments/Corrections | |
Comment In:
|
Evid Based Ment Health. 2010 Nov;13(4):108
[PMID:
21036970
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Stigma and depression treatment utilization among Latinos: utility of four stigma measures.
Next Document: Pregnancy-related discontinuation of antidepressants and depression care visits among medicaid recip...